Litcius/Paper detail

Recent development of VEGFR small molecule inhibitors as anticancer agents: A patent review (2021–2023)

Jing Zeng, Qichuan Deng, Zheng Chen, Shuang Yan, Qin Dong, Yuyu Zhang, Cui Yuan, Ling Li, Yuxin He, Jianyou Shi

2024Bioorganic Chemistry41 citationsDOI

Topics & Concepts

AngiogenesisCancer researchMetastasisTyrosine kinaseCancerReceptor tyrosine kinaseIn vivoCytotoxicitySunitinibPharmacologyChemistryMedicineReceptorBiologyIn vitroInternal medicineBiochemistryBiotechnologyAngiogenesis and VEGF in CancerCancer Mechanisms and TherapyCancer Cells and Metastasis
Recent development of VEGFR small molecule inhibitors as anticancer agents: A patent review (2021–2023) | Litcius